Published on
May 27, 2025
- 13:15 GMT
VERIGRAFT Achieves Regulatory Milestone in CVI Trial
Regulatory green light granted as VERIGRAFT completes recruitment in Phase I/II trial of its personalised vein graft for chronic venous insufficiency. GOTHENBURG, SWEDEN, May 27, 2025 /EINPresswire.com/ -- VERIGRAFT AB, a Swedish biotechnology company …
Distribution channels:
Banking, Finance & Investment Industry, Business & Economy
...
